Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. [electronic resource]
Producer: 20160415Description: e0117820 p. digitalISSN:- 1932-6203
- Adolescent
- Adult
- Antibodies, Protozoan -- immunology
- Antigens, Protozoan -- administration & dosage
- Dose-Response Relationship, Drug
- Dose-Response Relationship, Immunologic
- Female
- Hepatitis B Vaccines -- administration & dosage
- Humans
- Immunoglobulin G -- immunology
- India
- Malaria Vaccines -- administration & dosage
- Malaria, Falciparum -- immunology
- Male
- Mannitol -- administration & dosage
- Merozoite Surface Protein 1 -- administration & dosage
- Middle Aged
- Oleic Acids -- administration & dosage
- Plasmodium falciparum -- immunology
- Protozoan Proteins -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.